(Q42910422)

11 November 2017

title

Metformin treatment for Type 2 diabetes in pregnancy? (English)

1 reference

11 November 2017

0 references

1 reference

1 reference

1

David Simmons

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20832741

11 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20832741

11 July 2024

publication date

1 August 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S1521690X10000357?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

https://api.elsevier.com/content/article/PII:S1521690X10000357?httpAccept=text/plain

11 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Best Practice and Research: Clinical Endocrinology and Metabolism

11 July 2024

published in

1 reference

11 November 2017

volume

24

1 reference

11 November 2017

issue

4

1 reference

11 November 2017

page(s)

625-634

1 reference

Global and societal implications of the diabetes epidemic

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Risk of development of diabetes mellitus after diagnosis of gestational diabetes

11 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy

11 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Type 2 diabetes in pregnancy: a growing concern

11 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

11 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Metformin in management of pregnant insulin-independent diabetics

11 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

The management of non-insulin-dependent diabetes during pregnancy

11 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Prevention of type 2 diabetes in women with previous gestational diabetes

11 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

11 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

11 July 2024

Metformin: An Update

11

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Point: Oral hypoglycemic agents should not be used to treat diabetic pregnant women

11 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy

11 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Effect of pregnancy on the pharmacokinetics of metformin

11 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation

11 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study.

11 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Vitamin-B12 Status of Patients on Long-term Metformin Therapy

11 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin

11 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome

11 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Metformin versus insulin for the treatment of gestational diabetes

11 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

A comparison of glyburide and insulin in women with gestational diabetes mellitus

11 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

11 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis

11 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal

11 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Effects of in-utero exposure to oral hypoglycaemic drugs

11 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents

11 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Metformin use and diabetic pregnancy-has its time come?

11 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis

11 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

11 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Placental passage of metformin in women with polycystic ovary syndrome

11 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer

11 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women.

11 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Oral hypoglycaemic agents in 118 diabetic pregnancies.

11 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?

11 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study

11 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Transfer of metformin into human milk

11 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Transfer of metformin into human milk

11 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Effect of a diabetic environment in utero on predisposition to type 2 diabetes

11 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

11 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

11 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

11 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BEEM.2010.05.002

11 July 2024

Identifiers

1 reference

11 November 2017

1 reference